Sandvine CEO Dave Caputo.Sandvine’s (TSX:SVC) maturing channel partnership is creating greater earnings leverage for the Waterloo-based company, says M Partners analyst Ron Shuttleworth.
Last week, Sandvine reported its Q3, 2013 results. The company earned $4.65-million (U.S.) on revenue of $27.2-million, a topline that was up 25% over last year’s thrd quarter.
Shuttleworth says Sandvine Q3 EBITDA of $6.5-million was $1.0-million ahead of our forecast of $5.5-million and $1.6-million better than street consensus.
While revenue fell short of his estimate of $29-million, the company made up for this, he says, with gross margins that came in at 76%, which was 5% above his estimate and resulted in gross revenue of $20.6-million, in line with his estimate.
The M Partners analyst says there is very little recurring revenue in Sandvine’s business model, which makes its especially sensitive to macro-economic conditions. This has hurt the company in recent times, but Shuttleworth says an environment where the European debt crisis is receding and Asia-Pacific opportunities are emerging will make this flaw in the company’s business model less prominent.
In a research update to clients following the quarterly results, Shuttleworth maintained his BUY recommendation and increase our 12-month share price target to $2.60, up from his previous target of $2.40.
____________
Roth Capital Partners analyst Boobalan Pachaiyappan lowered his target on Gain Therapeutics (Gain Therapeutics Stock Quote, Chart, News, Analysts, Financials… [Read More]
WELLSTAR Technologies’ (WELLSTAR Technologies Corp. Stock Quote, Chart, News, Analysts, Financials TSXV:WSTR) first quarterly results as a public company exceeded… [Read More]
Volatus Aerospace’s (Volatus Aerospace Stock Quote, Chart, News, Analysts, Financials TSX:FLT) first Canadian Armed Forces contract and growing defence order… [Read More]
WELL Health Technologies’ (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL) Canadian clinic operations delivered strong third-quarter growth,… [Read More]
Quarterhill (Quarterhill Stock Quote, Chart, News, Analysts, Financials TSX:QTRH) remains on track to complete its acquisition of Conduent’s tolling business… [Read More]
Medicenna Therapeutics’ (Medicenna Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:MDNA) experimental cancer treatment MDNA11 produced encouraging responses in patients… [Read More]